The finding that IL-13Rα2 could enhance MAPK and STAT3 signaling in the presence of EGFRvIII was further confirmed using primary GBM from Mayo clinic that expressed endogenous EGFRvIII and IL-13Rα2. Here, IL13RA2 is linked to glioblastoma.